[go: up one dir, main page]

WO1996037207A3 - Compositions pharmaceutiques contenant du sulfate de calcium - Google Patents

Compositions pharmaceutiques contenant du sulfate de calcium Download PDF

Info

Publication number
WO1996037207A3
WO1996037207A3 PCT/US1996/007874 US9607874W WO9637207A3 WO 1996037207 A3 WO1996037207 A3 WO 1996037207A3 US 9607874 W US9607874 W US 9607874W WO 9637207 A3 WO9637207 A3 WO 9637207A3
Authority
WO
WIPO (PCT)
Prior art keywords
calcium sulfate
compositions
disclosed
methods
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1996/007874
Other languages
English (en)
Other versions
WO1996037207A2 (fr
Inventor
Sohail Malik
Rolland F Hebert
Min Yee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biofrontiers Inc
Original Assignee
Biofrontiers Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/449,949 external-priority patent/US5683725A/en
Application filed by Biofrontiers Inc filed Critical Biofrontiers Inc
Priority to AU60252/96A priority Critical patent/AU6025296A/en
Priority to EP96917844A priority patent/EP0839043A2/fr
Publication of WO1996037207A2 publication Critical patent/WO1996037207A2/fr
Publication of WO1996037207A3 publication Critical patent/WO1996037207A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions et des procédés pour moduler la substance P et prévenir et/ou traiter les états associés à la substance P. Dans un mode de réalisation, on décrit des compositions et des procédés pour prévenir et/ou traiter une parodonpathie, telle que la gingivite et la parodontite. Les compositions selon l'invention comprennent un composé de sulfate de calcium associé à un porteur ou un diluent pharmaceutiquement acceptable. Des composés de sulfate de calcium représentatifs comprennent la syngénite et la görgeyite. L'invention traite également de procédés de fabrication de la syngénite et de la görgeyite.
PCT/US1996/007874 1995-05-25 1996-05-28 Compositions pharmaceutiques contenant du sulfate de calcium Ceased WO1996037207A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU60252/96A AU6025296A (en) 1995-05-25 1996-05-28 Pharmaceutical compositions containing calcium sulfate
EP96917844A EP0839043A2 (fr) 1995-05-25 1996-05-28 Compositions pharmaceutiques contenant du sulfate de calcium

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US45026195A 1995-05-25 1995-05-25
US08/449,949 1995-05-25
US08/449,949 US5683725A (en) 1995-05-25 1995-05-25 Modulation of substance P by compounds containing calcium sulfate and methods relating thereto
US08/450,261 1995-05-25
US52924495A 1995-09-15 1995-09-15
US08/529,244 1995-09-15

Publications (2)

Publication Number Publication Date
WO1996037207A2 WO1996037207A2 (fr) 1996-11-28
WO1996037207A3 true WO1996037207A3 (fr) 1997-02-27

Family

ID=27412423

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/007874 Ceased WO1996037207A2 (fr) 1995-05-25 1996-05-28 Compositions pharmaceutiques contenant du sulfate de calcium

Country Status (3)

Country Link
EP (1) EP0839043A2 (fr)
AU (1) AU6025296A (fr)
WO (1) WO1996037207A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267962B1 (en) 1990-12-21 2001-07-31 C-P Technology Limited Partnership Compositions and methods of treatment using peat derivatives
CA2287397A1 (fr) * 1997-04-24 1998-10-29 Merck Sharp & Dohme Limited Utilisation d'un antagoniste du recepteur nk-1 et d'un inhibiteur selectif de reabsorption de la serotonine (ssri) dans le traitement de l'obesite
WO1998047513A1 (fr) * 1997-04-24 1998-10-29 Merck Sharp & Dohme Limited Utilisation des antagonistes du recepteur de nk-1 dans le traitement des troubles alimentaires
GB9816897D0 (en) * 1998-08-04 1998-09-30 Merck Sharp & Dohme Therapeutic use

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689223A (en) * 1986-04-24 1987-08-25 T & R Chemicals, Inc. Method of treating the symptoms of the common cold
US4735802A (en) * 1986-05-05 1988-04-05 Le Bich N Topical dermatological composition and method of treatment
WO1988009665A1 (fr) * 1987-06-01 1988-12-15 Allergan, Inc. Pommades ophtalmiques sans conservateurs
US4915936A (en) * 1988-10-31 1990-04-10 United States Gypsum Company Dental hygiene composition for reducing periodontal disease
WO1994009798A1 (fr) * 1992-10-29 1994-05-11 C-P Technology Limited Partnership Melanges ou complexes contenant du calcium et du sulfate
WO1995005752A1 (fr) * 1993-08-24 1995-03-02 Kappa Pharmaceuticals Limited Absorption reduite d'acides gras
JPH0899848A (ja) * 1994-10-03 1996-04-16 Yoshinori Akiyama 歯槽膿漏治療剤

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689223A (en) * 1986-04-24 1987-08-25 T & R Chemicals, Inc. Method of treating the symptoms of the common cold
US4735802A (en) * 1986-05-05 1988-04-05 Le Bich N Topical dermatological composition and method of treatment
WO1988009665A1 (fr) * 1987-06-01 1988-12-15 Allergan, Inc. Pommades ophtalmiques sans conservateurs
US4915936A (en) * 1988-10-31 1990-04-10 United States Gypsum Company Dental hygiene composition for reducing periodontal disease
WO1994009798A1 (fr) * 1992-10-29 1994-05-11 C-P Technology Limited Partnership Melanges ou complexes contenant du calcium et du sulfate
WO1995005752A1 (fr) * 1993-08-24 1995-03-02 Kappa Pharmaceuticals Limited Absorption reduite d'acides gras
JPH0899848A (ja) * 1994-10-03 1996-04-16 Yoshinori Akiyama 歯槽膿漏治療剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 9625, Derwent World Patents Index; Class B06, AN 96-246881, XP002015614 *

Also Published As

Publication number Publication date
WO1996037207A2 (fr) 1996-11-28
EP0839043A2 (fr) 1998-05-06
AU6025296A (en) 1996-12-11

Similar Documents

Publication Publication Date Title
IE890357L (en) Method for Preventing Secondary Effects
HU9601555D0 (en) Process for the preparation of microcapsule compositions
CY2369B1 (en) Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same.
ZA933768B (en) Novel phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism metabolism.
ZA997733B (en) Hydrazide compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA968956B (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
HUP0003305A3 (en) Hiv protease inhibiting tetrahydro-pyrimid-2-on derivative, pharmaceutical compositions containing it and process for producing the compound
ZA964337B (en) Pharmaceutical compositions containing irbesartan.
IL133575A0 (en) Sulfonamide compounds, a method for producing same and pharmaceutical compositions containing same
HUP9900055A3 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridin -derivatives, process for producing them and pharmaceutical compositions containing them
HUP9901209A3 (en) Opioid-like peptide compounds, process for producing them and pharmaceutical compositions containing them
HUP9601034A2 (en) Aryl-alkyl-pyridazinone compounds, process for producing them, and pharmaceutical compositions containing them
EG24080A (en) New arylglycineamide derivatives, process for thw manufacture thereof and pharmaceutical compositions containing these compounds
EP0807633A3 (fr) (5,6)-Pyrimidin-4-ones condensées à hétéroaryle, substituées en 2,3
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
IL118426A0 (en) Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative
IL117940A (en) Benzylsulfide derivatives, process for their production and insecticide compositions containing them
ZA961138B (en) Solid active ingredient compositions containing hydroxypropylcellulose.
WO1994023691A3 (fr) Compositions orales de traitement de la plaque dentaire et de la gingivite, contenant un agent antibacterien non cationique et un sel de bicarbonate
HU9701660D0 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, find pharmaceutical compositions containing them
WO1996037207A3 (fr) Compositions pharmaceutiques contenant du sulfate de calcium
IL120966A (en) 1, 4 - diaryl - 2 - fluoro - 2 - butene compounds, compositions containing them, processes for the preparation of such compounds and methods of using such compounds and compositions for the control of insect and acarid petsts
HUP9601976A3 (en) 4-fluoralkyl benzoylguanidines, process for producing them and pharmaceutical compositions containing these compounds
IL105474A0 (en) Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis
ZA931593B (en) 2,4-Thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1996917844

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1996917844

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1996917844

Country of ref document: EP